These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 37213231)

  • 1. LAPTM4B-YAP loop feedback amplification enhances the stemness of hepatocellular carcinoma.
    Liao J; Wang J; Xu Y; Wu Y; Wang M; Zhao Q; Tan X; Meng Y; Wei L; Huang A
    iScience; 2023 Jun; 26(6):106754. PubMed ID: 37213231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of lysosome-associated protein transmembrane-4β gene overexpression with the malignant phenotypes of hepatocellular carcinoma.
    Su H; Xu T; Huang X; Zang S; Wang B; Huang Y; Liu J; Huang A
    Pathol Res Pract; 2017 Dec; 213(12):1536-1541. PubMed ID: 29108920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AP4 positively regulates LAPTM4B to promote hepatocellular carcinoma growth and metastasis, while reducing chemotherapy sensitivity.
    Meng Y; Wang L; Xu J; Zhang Q
    Mol Oncol; 2018 Mar; 12(3):373-390. PubMed ID: 29337428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of lysosome-associated protein transmembrane 4B-35 in cancer and its correlation with the differentiation status of hepatocellular carcinoma.
    Peng C; Zhou RL; Shao GZ; Rui JA; Wang SB; Lin M; Zhang S; Gao ZF
    World J Gastroenterol; 2005 May; 11(18):2704-8. PubMed ID: 15884107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Serum LAPTM4B-35 protein as a novel diagnostic marker for hepatocellular carcinoma].
    Pang Y; Zhang S; Yang H; Zhou RL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Aug; 53(4):710-715. PubMed ID: 34393233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A positive feedback loop between Periostin and TGFβ1 induces and maintains the stemness of hepatocellular carcinoma cells via AP-2α activation.
    Chen G; Wang Y; Zhao X; Xie XZ; Zhao JG; Deng T; Chen ZY; Chen HB; Tong YF; Yang Z; Ding XW; Guo PY; Yu HT; Wu LJ; Zhang SN; Zhu QD; Li JJ; Shan YF; Yu FX; Yu ZP; Xia JL
    J Exp Clin Cancer Res; 2021 Jun; 40(1):218. PubMed ID: 34193219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LAPTM4B facilitates tumor growth and induces autophagy in hepatocellular carcinoma.
    Wang F; Wu H; Zhang S; Lu J; Lu Y; Zhan P; Fang Q; Wang F; Zhang X; Xie C; Yin Z
    Cancer Manag Res; 2019; 11():2485-2497. PubMed ID: 31118766
    [No Abstract]   [Full Text] [Related]  

  • 8. LAPTM4B-35 overexpression is a risk factor for tumor recurrence and poor prognosis in hepatocellular carcinoma.
    Yang H; Xiong FX; Lin M; Yang Y; Nie X; Zhou RL
    J Cancer Res Clin Oncol; 2010 Feb; 136(2):275-81. PubMed ID: 19690886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. STARD13 is positively correlated with good prognosis and enhances 5-FU sensitivity via suppressing cancer stemness in hepatocellular carcinoma cells.
    Gao F; Yu X; Meng R; Wang J; Jia L
    Onco Targets Ther; 2018; 11():5371-5381. PubMed ID: 30214243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure analysis and expressions of a novel tetratransmembrane protein, lysosoma-associated protein transmembrane 4 beta associated with hepatocellular carcinoma.
    Liu XR; Zhou RL; Zhang QY; Zhang Y; Jin YY; Lin M; Rui JA; Ye DX
    World J Gastroenterol; 2004 Jun; 10(11):1555-9. PubMed ID: 15162524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting a novel cancer-driving protein (LAPTM4B-35) by a small molecule (ETS) to inhibit cancer growth and metastasis.
    Li M; Zhou R; Shan Y; Li L; Wang L; Liu G
    Oncotarget; 2016 Sep; 7(36):58531-58542. PubMed ID: 27542271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LAPTM4B-35 is a novel prognostic factor of hepatocellular carcinoma.
    Yang H; Xiong F; Qi R; Liu Z; Lin M; Rui J; Su J; Zhou R
    J Surg Oncol; 2010 Apr; 101(5):363-9. PubMed ID: 20358632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CXCR4 mediates matrix stiffness-induced downregulation of UBTD1 driving hepatocellular carcinoma progression via YAP signaling pathway.
    Yang N; Chen T; Wang L; Liu R; Niu Y; Sun L; Yao B; Wang Y; Yang W; Liu Q; Tu K; Liu Z
    Theranostics; 2020; 10(13):5790-5801. PubMed ID: 32483419
    [No Abstract]   [Full Text] [Related]  

  • 14. The membrane protein melanoma cell adhesion molecule (MCAM) is a novel tumor marker that stimulates tumorigenesis in hepatocellular carcinoma.
    Wang J; Tang X; Weng W; Qiao Y; Lin J; Liu W; Liu R; Ma L; Yu W; Yu Y; Pan Q; Sun F
    Oncogene; 2015 Nov; 34(47):5781-95. PubMed ID: 25728681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. USP22 promotes hypoxia-induced hepatocellular carcinoma stemness by a HIF1α/USP22 positive feedback loop upon TP53 inactivation.
    Ling S; Shan Q; Zhan Q; Ye Q; Liu P; Xu S; He X; Ma J; Xiang J; Jiang G; Wen X; Feng Z; Wu Y; Feng T; Xu L; Chen K; Zhang X; Wei R; Zhang C; Cen B; Xie H; Song P; Liu J; Zheng S; Xu X
    Gut; 2020 Jul; 69(7):1322-1334. PubMed ID: 31776228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneous matrix stiffness regulates the cancer stem-like cell phenotype in hepatocellular carcinoma.
    Wei J; Yao J; Yang C; Mao Y; Zhu D; Xie Y; Liu P; Yan M; Ren L; Lin Y; Zheng Q; Li X
    J Transl Med; 2022 Dec; 20(1):555. PubMed ID: 36463272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of LAPTM4B-35 promotes growth and metastasis of hepatocellular carcinoma in vitro and in vivo.
    Yang H; Xiong F; Wei X; Yang Y; McNutt MA; Zhou R
    Cancer Lett; 2010 Aug; 294(2):236-44. PubMed ID: 20202745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Yes-associated protein (YAP) binds to HIF-1α and sustains HIF-1α protein stability to promote hepatocellular carcinoma cell glycolysis under hypoxic stress.
    Zhang X; Li Y; Ma Y; Yang L; Wang T; Meng X; Zong Z; Sun X; Hua X; Li H
    J Exp Clin Cancer Res; 2018 Sep; 37(1):216. PubMed ID: 30180863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysosome-associated protein transmembrane-4β-35 is a novel independent prognostic factor in small cell lung cancer.
    Qiao M; Hu G
    Tumour Biol; 2015 Sep; 36(10):7493-9. PubMed ID: 25910706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Clinicopathological Significance of YAP/TAZ Expression in Hepatocellular Carcinoma with Relation to Hypoxia and Stemness.
    Park H; Lee Y; Lee K; Lee H; Yoo JE; Ahn S; Park YN; Kim H
    Pathol Oncol Res; 2021; 27():604600. PubMed ID: 34257565
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.